NEU neuren pharmaceuticals limited

Ann: NEU confirms primary endpoints for Phase 3 trial in PMS, page-42

  1. 2,756 Posts.
    lightbulb Created with Sketch. 1062
    Distribution deal not off the table but unlikely based on CEO commentary. Acquisition of a company setup for distribution is likely to be well out of our league. Merger a possibility but based on commentary it does seem we are being dressed up for sale and that TO is most likely path seen to deliver shareholder return
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.